Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Esonadogene imvoparvovec by Wuhan Neurophth Biological Technology for Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy): Likelihood of Approval
Esonadogene imvoparvovec is under clinical development by Wuhan Neurophth Biological Technology and currently in Phase II for Leber's Hereditary Optic...